
Global Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Pediatric Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pediatric Vaccines include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pediatric Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Pediatric Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Pediatric Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pediatric Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pediatric Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pediatric Vaccines sales, projected growth trends, production technology, application and end-user industry.
Pediatric Vaccines Segment by Company
Bavarian Nordic
Bharat Biotech
Crucell
Dynavax
LG Life Sciences
Lupin
Mitsubishi Tanabe Pharma
S K Chemicals
Serum Institute of India
Sinovac Biotech
AstraZeneca
Baxter
GlaxoSmithKline
Pfizer
Merck
Novartis
Sanofi
Shenzhen Kangtai Biological Products
Takeda Pharmaceutical
Janssen
Pediatric Vaccines Segment by Type
Meningococcal Diseases
Influenza
Hepatitis
Pneumococcal Diseases
Diphtheria
Others
Pediatric Vaccines Segment by Application
Infant
Newborn
Dolescent
Child
Pediatric Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pediatric Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Pediatric Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pediatric Vaccines include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pediatric Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Pediatric Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Pediatric Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pediatric Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pediatric Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pediatric Vaccines sales, projected growth trends, production technology, application and end-user industry.
Pediatric Vaccines Segment by Company
Bavarian Nordic
Bharat Biotech
Crucell
Dynavax
LG Life Sciences
Lupin
Mitsubishi Tanabe Pharma
S K Chemicals
Serum Institute of India
Sinovac Biotech
AstraZeneca
Baxter
GlaxoSmithKline
Pfizer
Merck
Novartis
Sanofi
Shenzhen Kangtai Biological Products
Takeda Pharmaceutical
Janssen
Pediatric Vaccines Segment by Type
Meningococcal Diseases
Influenza
Hepatitis
Pneumococcal Diseases
Diphtheria
Others
Pediatric Vaccines Segment by Application
Infant
Newborn
Dolescent
Child
Pediatric Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pediatric Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
196 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pediatric Vaccines Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Pediatric Vaccines Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Pediatric Vaccines Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Pediatric Vaccines Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Pediatric Vaccines Market Dynamics
- 2.1 Pediatric Vaccines Industry Trends
- 2.2 Pediatric Vaccines Industry Drivers
- 2.3 Pediatric Vaccines Industry Opportunities and Challenges
- 2.4 Pediatric Vaccines Industry Restraints
- 3 Pediatric Vaccines Market by Manufacturers
- 3.1 Global Pediatric Vaccines Revenue by Manufacturers (2020-2025)
- 3.2 Global Pediatric Vaccines Sales by Manufacturers (2020-2025)
- 3.3 Global Pediatric Vaccines Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Pediatric Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Pediatric Vaccines Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pediatric Vaccines Manufacturers, Product Type & Application
- 3.7 Global Pediatric Vaccines Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pediatric Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pediatric Vaccines Players Market Share by Revenue in 2024
- 3.8.3 2024 Pediatric Vaccines Tier 1, Tier 2, and Tier 3
- 4 Pediatric Vaccines Market by Type
- 4.1 Pediatric Vaccines Type Introduction
- 4.1.1 Meningococcal Diseases
- 4.1.2 Influenza
- 4.1.3 Hepatitis
- 4.1.4 Pneumococcal Diseases
- 4.1.5 Diphtheria
- 4.1.6 Others
- 4.2 Global Pediatric Vaccines Sales by Type
- 4.2.1 Global Pediatric Vaccines Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Pediatric Vaccines Sales by Type (2020-2031)
- 4.2.3 Global Pediatric Vaccines Sales Market Share by Type (2020-2031)
- 4.3 Global Pediatric Vaccines Revenue by Type
- 4.3.1 Global Pediatric Vaccines Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Pediatric Vaccines Revenue by Type (2020-2031)
- 4.3.3 Global Pediatric Vaccines Revenue Market Share by Type (2020-2031)
- 5 Pediatric Vaccines Market by Application
- 5.1 Pediatric Vaccines Application Introduction
- 5.1.1 Infant
- 5.1.2 Newborn
- 5.1.3 Dolescent
- 5.1.4 Child
- 5.2 Global Pediatric Vaccines Sales by Application
- 5.2.1 Global Pediatric Vaccines Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Pediatric Vaccines Sales by Application (2020-2031)
- 5.2.3 Global Pediatric Vaccines Sales Market Share by Application (2020-2031)
- 5.3 Global Pediatric Vaccines Revenue by Application
- 5.3.1 Global Pediatric Vaccines Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Pediatric Vaccines Revenue by Application (2020-2031)
- 5.3.3 Global Pediatric Vaccines Revenue Market Share by Application (2020-2031)
- 6 Global Pediatric Vaccines Sales by Region
- 6.1 Global Pediatric Vaccines Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Pediatric Vaccines Sales by Region (2020-2031)
- 6.2.1 Global Pediatric Vaccines Sales by Region (2020-2025)
- 6.2.2 Global Pediatric Vaccines Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Pediatric Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Pediatric Vaccines Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pediatric Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Pediatric Vaccines Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pediatric Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Pediatric Vaccines Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pediatric Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Pediatric Vaccines Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Pediatric Vaccines Revenue by Region
- 7.1 Global Pediatric Vaccines Revenue by Region
- 7.1.1 Global Pediatric Vaccines Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Pediatric Vaccines Revenue by Region (2020-2025)
- 7.1.3 Global Pediatric Vaccines Revenue by Region (2026-2031)
- 7.1.4 Global Pediatric Vaccines Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Pediatric Vaccines Revenue (2020-2031)
- 7.2.2 North America Pediatric Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Pediatric Vaccines Revenue (2020-2031)
- 7.3.2 Europe Pediatric Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pediatric Vaccines Revenue (2020-2031)
- 7.4.2 Asia-Pacific Pediatric Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pediatric Vaccines Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Pediatric Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Bavarian Nordic
- 8.1.1 Bavarian Nordic Comapny Information
- 8.1.2 Bavarian Nordic Business Overview
- 8.1.3 Bavarian Nordic Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
- 8.1.5 Bavarian Nordic Recent Developments
- 8.2 Bharat Biotech
- 8.2.1 Bharat Biotech Comapny Information
- 8.2.2 Bharat Biotech Business Overview
- 8.2.3 Bharat Biotech Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Bharat Biotech Pediatric Vaccines Product Portfolio
- 8.2.5 Bharat Biotech Recent Developments
- 8.3 Crucell
- 8.3.1 Crucell Comapny Information
- 8.3.2 Crucell Business Overview
- 8.3.3 Crucell Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Crucell Pediatric Vaccines Product Portfolio
- 8.3.5 Crucell Recent Developments
- 8.4 Dynavax
- 8.4.1 Dynavax Comapny Information
- 8.4.2 Dynavax Business Overview
- 8.4.3 Dynavax Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Dynavax Pediatric Vaccines Product Portfolio
- 8.4.5 Dynavax Recent Developments
- 8.5 LG Life Sciences
- 8.5.1 LG Life Sciences Comapny Information
- 8.5.2 LG Life Sciences Business Overview
- 8.5.3 LG Life Sciences Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 LG Life Sciences Pediatric Vaccines Product Portfolio
- 8.5.5 LG Life Sciences Recent Developments
- 8.6 Lupin
- 8.6.1 Lupin Comapny Information
- 8.6.2 Lupin Business Overview
- 8.6.3 Lupin Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Lupin Pediatric Vaccines Product Portfolio
- 8.6.5 Lupin Recent Developments
- 8.7 Mitsubishi Tanabe Pharma
- 8.7.1 Mitsubishi Tanabe Pharma Comapny Information
- 8.7.2 Mitsubishi Tanabe Pharma Business Overview
- 8.7.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
- 8.7.5 Mitsubishi Tanabe Pharma Recent Developments
- 8.8 S K Chemicals
- 8.8.1 S K Chemicals Comapny Information
- 8.8.2 S K Chemicals Business Overview
- 8.8.3 S K Chemicals Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 S K Chemicals Pediatric Vaccines Product Portfolio
- 8.8.5 S K Chemicals Recent Developments
- 8.9 Serum Institute of India
- 8.9.1 Serum Institute of India Comapny Information
- 8.9.2 Serum Institute of India Business Overview
- 8.9.3 Serum Institute of India Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Serum Institute of India Pediatric Vaccines Product Portfolio
- 8.9.5 Serum Institute of India Recent Developments
- 8.10 Sinovac Biotech
- 8.10.1 Sinovac Biotech Comapny Information
- 8.10.2 Sinovac Biotech Business Overview
- 8.10.3 Sinovac Biotech Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.10.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
- 8.10.5 Sinovac Biotech Recent Developments
- 8.11 AstraZeneca
- 8.11.1 AstraZeneca Comapny Information
- 8.11.2 AstraZeneca Business Overview
- 8.11.3 AstraZeneca Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.11.4 AstraZeneca Pediatric Vaccines Product Portfolio
- 8.11.5 AstraZeneca Recent Developments
- 8.12 Baxter
- 8.12.1 Baxter Comapny Information
- 8.12.2 Baxter Business Overview
- 8.12.3 Baxter Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.12.4 Baxter Pediatric Vaccines Product Portfolio
- 8.12.5 Baxter Recent Developments
- 8.13 GlaxoSmithKline
- 8.13.1 GlaxoSmithKline Comapny Information
- 8.13.2 GlaxoSmithKline Business Overview
- 8.13.3 GlaxoSmithKline Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.13.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
- 8.13.5 GlaxoSmithKline Recent Developments
- 8.14 Pfizer
- 8.14.1 Pfizer Comapny Information
- 8.14.2 Pfizer Business Overview
- 8.14.3 Pfizer Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.14.4 Pfizer Pediatric Vaccines Product Portfolio
- 8.14.5 Pfizer Recent Developments
- 8.15 Merck
- 8.15.1 Merck Comapny Information
- 8.15.2 Merck Business Overview
- 8.15.3 Merck Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.15.4 Merck Pediatric Vaccines Product Portfolio
- 8.15.5 Merck Recent Developments
- 8.16 Novartis
- 8.16.1 Novartis Comapny Information
- 8.16.2 Novartis Business Overview
- 8.16.3 Novartis Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.16.4 Novartis Pediatric Vaccines Product Portfolio
- 8.16.5 Novartis Recent Developments
- 8.17 Sanofi
- 8.17.1 Sanofi Comapny Information
- 8.17.2 Sanofi Business Overview
- 8.17.3 Sanofi Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.17.4 Sanofi Pediatric Vaccines Product Portfolio
- 8.17.5 Sanofi Recent Developments
- 8.18 Shenzhen Kangtai Biological Products
- 8.18.1 Shenzhen Kangtai Biological Products Comapny Information
- 8.18.2 Shenzhen Kangtai Biological Products Business Overview
- 8.18.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.18.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
- 8.18.5 Shenzhen Kangtai Biological Products Recent Developments
- 8.19 Takeda Pharmaceutical
- 8.19.1 Takeda Pharmaceutical Comapny Information
- 8.19.2 Takeda Pharmaceutical Business Overview
- 8.19.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.19.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
- 8.19.5 Takeda Pharmaceutical Recent Developments
- 8.20 Janssen
- 8.20.1 Janssen Comapny Information
- 8.20.2 Janssen Business Overview
- 8.20.3 Janssen Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.20.4 Janssen Pediatric Vaccines Product Portfolio
- 8.20.5 Janssen Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Pediatric Vaccines Value Chain Analysis
- 9.1.1 Pediatric Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pediatric Vaccines Production Mode & Process
- 9.2 Pediatric Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pediatric Vaccines Distributors
- 9.2.3 Pediatric Vaccines Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.